Most cited papers from Nini Hospital

Nini Hospital

What are the most cited papers from Nini Hospital?

The most cited paper from Nini Hospital is "Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy" (Howard I. Scher, Karim S. Fizazi, Fred Saad et al., 2012), with 4,645 citations. Next come "Abiraterone and Increased Survival in Metastatic Prostate Cancer" (4,448) and "Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma" (3,457).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 98 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Howard I. Scher, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine Open access	15 Aug 2012	4,645
2	Abiraterone and Increased Survival in Metastatic Prostate Cancer Johann Sebastian De Bono et al. · New England Journal of Medicine Open access	25 May 2011	4,448
3	Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine Open access	17 Feb 2017	3,457
4	Enzalutamide in Metastatic Prostate Cancer before Chemotherapy Tomasz M. Beer et al. · New England Journal of Medicine Open access	Jun 2014	3,076
5	Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access	21 Aug 2013	1,936
6	Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Maha Hussain, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine Open access	27 Jun 2018	1,062
7	PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Luis G Paz-Ares, Filippo de Marinis, Mircea Dediu et al. · Journal of Clinical Oncology	8 Jul 2013	639
8	A framework for the classification of joint hypermobility and related conditions Marco Castori, Brad T. Tinkle, Howard P. Levy et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics Open access	Feb 2017	613
9	Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial Cora Nanette Sternberg et al. · The Lancet Oncology	11 Dec 2014	390
10	ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment Hannah B. Gordon et al. · Journal of Crohn s and Colitis Open access	11 Jun 2024	374
11	Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair (CAESAR): Results from a Randomised Trial Piergiorgio Cao, Paola De Rango, Fabio Verzini et al. · European Journal of Vascular and Endovascular Surgery Open access	27 Sep 2010	298
12	An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels José de León et al. · Pharmacopsychiatry Open access104 authors	15 Dec 2021	274
13	Adjustable fortification of human milk fed to preterm infants: does it make a difference? Sertaç Arslanoğlu, Guido Eugenio Moro, Ekhard E. Ziegler · Journal of Perinatology	3 Aug 2006	261
14	Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients Riccardo Maria Fagugli, Gianpaolo Reboldi, Giuseppe Quintaliani et al. · American Journal of Kidney Diseases	Aug 2001	238
15	Affective and cognitive empathy in adolescents with autism spectrum disorder Monica Mazza, Maria Chiara Pino, Melania Mariano et al. · Frontiers in Human Neuroscience Open access	7 Oct 2014	229
16	Gender-related differences in catheter ablation of atrial fibrillation Giovanni B. Forleo, Claudio Tondo, Lucia De Luca et al. · EP Europace Open access	18 Jul 2007	195
17	IRAD experience on surgical type A acute dissection patients: results and predictors of mortality Paolo Berretta, Himanshu J. Patel, Thomas G. Gleason et al. · Annals of Cardiothoracic Surgery Open access	Jul 2016	193
18	Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II) Silvio Danese, Severine A.R.A. Vermeire, Paul A. Hellstern et al. · Gut Open access	15 Dec 2017	181
19	Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006 A. Bortoli, N Pedersen, Dana Ďuricová et al. · Alimentary Pharmacology & Therapeutics	4 Aug 2011	181
20	ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment Michel Adamina et al. · Journal of Crohn s and Colitis Open access	15 Jun 2024	180
21	Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors Jean‐Charles Soria, Frances Alice Shepherd, Jean‐Yves Douillard et al. · Annals of Oncology Open access	24 Jun 2009	165
22	Re‐writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers–Danlos syndrome, hypermobility type Marco Castori, Silvia Morlino, Claudia Celletti et al. · American Journal of Medical Genetics Part A	6 Nov 2013	163
23	The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial Evandro de Azambuja, Worta McCaskill‐Stevens, Prudence A. Francis et al. · Breast Cancer Research and Treatment Open access	2 Sep 2009	161
24	NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome Alessandro De Luca, Irene Bottillo, Anna Sárközy et al. · The American Journal of Human Genetics Open access	7 Nov 2005	154
25	Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy Alessio Cortellini et al. · Journal for ImmunoTherapy of Cancer Open access	Apr 2021	152
26	Countrywide Spread of Community- and Hospital-Acquired Extended-Spectrum β-Lactamase (CTX-M-15)-Producing Enterobacteriaceae in Lebanon Carole Ayoub Moubareck, Ziad Daoud, Noha Hakimé et al. · Journal of Clinical Microbiology Open access	Jul 2005	147
27	Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data Kamal Chamoun et al. · International Journal of Infectious Diseases Open access	17 Mar 2016	146
28	Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants Hanne Eknes Puntervoll et al. · Journal of Medical Genetics Open access	5 Feb 2013	141
29	High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study The Italian TTP Study Group et al. · Annals of Hematology Open access	22 Dec 2009	138
30	Stress, Burnout, and Resilience among Healthcare Workers during the COVID-19 Emergency: The Role of Defense Mechanisms Mariagrazia Di Giuseppe, Gianni Nepa, Tracy A. Prout et al. · International Journal of Environmental Research and Public Health Open access	14 May 2021	136
31	Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract Cora Nanette Sternberg, Yohann Loriot, Nicholas David James et al. · European Urology Open access	23 Mar 2019	136
32	ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016 Christian Dittrich et al. · ESMO Open Open access	2016	131
33	Unraveling treatment response in multiple sclerosis Claudio Gasperini et al. · Neurology Open access	27 Dec 2018	130
34	Accuracy of ChatGPT‐Generated Information on Head and Neck and Oromaxillofacial Surgery: A Multicenter Collaborative Analysis Luigi Angelo Vaira et al. · Otolaryngology Open access	18 Aug 2023	126
35	Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine	12 May 2021	126
36	Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes Daniele Cazzato, Marco Castori, Raffaella Lombardi et al. · Neurology Open access	16 Jun 2016	125
37	Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers Josep M. Tabernero, Malvika Vyas, Rosa Giuliani et al. · ESMO Open Open access	2016	124
38	Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD) Marco Daperno, Michele Comberlato, Fabrizio Bossa et al. · Digestive and Liver Disease	19 Aug 2014	122
39	Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs Giuseppe Nardi, Vanessa Wegner Agostini, Beatrice Rondinelli et al. · Critical Care Open access	25 Feb 2015	122
40	Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function Claudio Tondo, Massimo Mantica, Giovanni Russo et al. · Pacing and Clinical Electrophysiology	Sep 2006	118
41	Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review Michele Fornaro, Domenico De Berardis, Ann Sarah Koshy et al. · Neuropsychiatric Disease and Treatment ReviewOpen access	Mar 2016	117
42	A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single‐blind randomized controlled trial Luca Paolo Weltert, Beatrice Rondinelli, Ricardo A. Bello et al. · Transfusion	23 Feb 2015	117
43	Mechanical Ventilation in Patients with End-Stage Idiopathic Pulmonary Fibrosis Corrado Mollica, Gregorino Paone, Vittoria Conti et al. · Respiration Open access	17 Jun 2009	115
44	Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor study Giovanni Donato Aquaro, Giovanni Salvatore Camastra, Lorenzo Monti et al. · Journal of Magnetic Resonance Imaging Open access	29 Aug 2016	114
45	Multiparametric Prognostic Scores in Chronic Heart Failure with Reduced Ejection Fraction: A Long-Term Comparison Piergiuseppe Agostoni et al. · European Journal of Heart Failure Open access	26 Sep 2017	109
46	Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients Giuseppe Marazzi, Luca Cacciotti, Francesco Pelliccia et al. · Advances in Therapy	21 Nov 2011	108
47	Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas Cosimo Durante, Marco Attard, Massimo Torlontano et al. · The Journal of Clinical Endocrinology & Metabolism Open access	22 Jul 2010	108
48	The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs Rosamaria Capuano, Marco Santonico, Giorgio Pennazza et al. · Scientific Reports Open access	12 Nov 2015	106
49	Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing Antonella Matteocci, Luca Pierelli · Vox Sanguinis Open access	9 Oct 2013	106
50	Influence of Feelings of Burden on the Caregiver's Perception of the Patient's Functional Status Carlos Alberto Mangone, R.M. Sanguinetti, Patricia D. Baumann et al. · Dementia and Geriatric Cognitive Disorders	1993	105

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.